MDXG Q2 2020 Earnings — MiMedx Group, Inc. Revenue & Financial Results | Market Cap Arena

MDXGMiMedx Group, Inc.

$666M

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$54M-20.4% YoY

Gross Profit

$45M84.7% margin

Operating Income

-$6M-10.9% margin

Net Income

-$8M-15.8% margin

EPS (Diluted)

$-0.08

QoQ Revenue Growth

-13.1%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$4M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$151M

Total Liabilities

$128M

Stockholders' Equity

$23M

Cash & Equivalents

$48M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$54M	$67M	-20.4%
Gross Profit	$45M	$58M	-21.2%
Operating Income	-$6M	-$17M	+65.7%
Net Income	-$8M	-$17M	+50.8%